Effect of autologous cytokine induced killer cell therapy in patients with lung cancer
10.11904/j.issn.1002-3070.2015.04.011
- VernacularTitle:自体细胞因子诱导的杀伤细胞治疗肺癌患者的临床疗效观察
- Author:
Likun ZHANG
;
Fenglin CAO
- Publication Type:Journal Article
- Keywords:
CIK cells;
Lung cancer;
Cellular immune
- From:
Practical Oncology Journal
2015;(4):342-346
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of cytokine induced killer cellular immunotherapies ( CIK) on the patients with advanced lung cancer.Methods Peripheral blood mononuclear cell from 32 cases of patients with advanced lung cancer were isolated.Cells were cultured in DMEM supplemented with IFN-γ,IL-2,anti-CD3 monoclonal antibody and other cytokines,and transfused back into the patients in several times after 15 days of culture.Subsequently,we observed the size of tumor,the change of immunologic function by CIK treat-ment,the status of clinical symptoms,and the toxic and side effect.The clinical curative effect was also evaluated. Results The symptoms in 32 patients who received CIK therapy were reduced,and the side effects were light. Immunophenotype analysis showed that CD3 /CD4 coexpression were found in 34.4%patients,CD3 /CD8 co-expression in 68.2%,and CD3 /CD56 co-expression in 13.7% patients.CT images about 15 days after CIK cell transfusion showed that pleural effusion were decreased.Clinical evaluation effective rate was 56.0%,and disease control rate( CR +PR +SD) was 84.3%.Conclusion CIK cell immunotherapies of cancer patients can improve immunologic function of cancer patients and inhibit tumor growth and relieve the clinical symptom of patients,and improve the quality of life.
